Clinical Trial Update: Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GW856553 effects on endothelial function and vascular compliance in individuals with dyslipidemia; the trial status shows completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• GW856553

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Dyslipidaemias | Phase 2 | Status: COMPLETED